Literature DB >> 15465279

Role of cytokines and chemokines in prion infections of the central nervous system.

Michael Burwinkel1, Constanze Riemer, Anja Schwarz, Julia Schultz, Sabine Neidhold, Theresa Bamme, Michael Baier.   

Abstract

Prion infections of the central nervous system (CNS) are characterised by a reactive gliosis and the subsequent degeneration of neuronal tissue. The activation of glial cells, which precedes neuronal death, is likely to be initially caused by the deposition of misfolded, proteinase K-resistant, isoforms (termed PrP(res)) of the prion protein (PrP) in the brain. Cytokines and chemokines released by PrP(res)-activated glia cells may contribute directly or indirectly to the disease development by enhancement and generalisation of the gliosis and via cytotoxicity for neurons. However, the actual role of prion-induced glia activation and subsequent cytokine/chemokine secretion in disease development is still far from clear. In the present work, we review our present knowledge concerning the functional biology of cytokines and chemokines in prion infections of the CNS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465279     DOI: 10.1016/j.ijdevneu.2004.07.017

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  16 in total

1.  Gene expression profiling of human primary astrocytes exposed to manganese chloride indicates selective effects on several functions of the cells.

Authors:  Amitabha Sengupta; Sarah M Mense; Changgui Lan; Mei Zhou; Rory E Mauro; Lisa Kellerman; Galina Bentsman; David J Volsky; Elan D Louis; Joseph H Graziano; Li Zhang
Journal:  Neurotoxicology       Date:  2006-11-07       Impact factor: 4.294

2.  Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration.

Authors:  David Vergote; Georgina S Butler; Martine Ooms; Jennifer H Cox; Claudia Silva; Morley D Hollenberg; Jack H Jhamandas; Christopher M Overall; Christopher Power
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

Review 3.  The intricate mechanisms of neurodegeneration in prion diseases.

Authors:  Claudio Soto; Nikunj Satani
Journal:  Trends Mol Med       Date:  2011-01       Impact factor: 11.951

4.  Role of cyclophilin A from brains of prion-infected mice in stimulation of cytokine release by microglia and astroglia in vitro.

Authors:  Déborah Tribouillard-Tanvier; James A Carroll; Roger A Moore; James F Striebel; Bruce Chesebro
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

5.  Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Natsuo Ohsawa; Kiminori Nakamura; Hirofumi Hamada; Hidefumi Furuoka; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

6.  Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.

Authors:  Déborah Tribouillard-Tanvier; James F Striebel; Karin E Peterson; Bruce Chesebro
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

7.  Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice.

Authors:  Constanze Riemer; Julia Schultz; Michael Burwinkel; Anja Schwarz; Simon W F Mok; Sandra Gültner; Theresa Bamme; Stephen Norley; Frank van Landeghem; Bao Lu; Craig Gerard; Michael Baier
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

8.  Prion protein expression differences in microglia and astroglia influence scrapie-induced neurodegeneration in the retina and brain of transgenic mice.

Authors:  Lisa Kercher; Cynthia Favara; James F Striebel; Rachel LaCasse; Bruce Chesebro
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

9.  Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression.

Authors:  Rachel A LaCasse; James F Striebel; Cynthia Favara; Lisa Kercher; Bruce Chesebro
Journal:  J Neuroimmunol       Date:  2008-04-08       Impact factor: 3.478

10.  Association mapping of genetic risk factors for chronic wasting disease in wild deer.

Authors:  Tomomi Matsumoto; Michael D Samuel; Trent Bollinger; Margo Pybus; David W Coltman
Journal:  Evol Appl       Date:  2012-08-30       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.